Yu Fan
Luzhou Key Laboratory Of Molecular Cancer
Luzhou, China
Luzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comprehensive Analysis of m6A Regulators Identifies YTHDF3 as a Promising Prognostic Biomarker for Breast Cancer.
Journal: Journal of visualized experiments : JoVE
Published: August 18, 2026
Novel strategies to overcome the blood-brain barrier in triple-negative breast cancer brain metastases.
Journal: The Lancet. Oncology
Published: February 10, 2026
Distinct prognostic patterns of single hormone receptor-positive subtypes in HER2-negative breast cancer: a SEER-based retrospective cohort study.
Journal: International journal of surgery (London, England)
Published: September 08, 2025
Tumor-associated neutrophils in breast cancer: an angel or a devil?
Journal: Frontiers in immunology
Published: March 13, 2025
GM-CSF augmented the photothermal immunotherapeutic outcome of self-driving gold nanoparticles against a mouse CT-26 colon tumor model.
Journal: Biomaterials research
Published: June 26, 2023
Zinc finger and SCAN domain-containing protein 18 is a potential DNA methylation-modified tumor suppressor and biomarker in breast cancer.
Journal: Frontiers in endocrinology
Published: November 11, 2022
Bacteria-driven hypoxia targeting delivery of chemotherapeutic drug proving outcome of breast cancer.
Journal: Journal of nanobiotechnology
Published: January 04, 2022
CLIP4 Shows Putative Tumor Suppressor Characteristics in Breast Cancer: An Integrated Analysis.
Journal: Frontiers in molecular biosciences
Published: October 11, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026